Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial): protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatment

Autor: N Roescher, JM Prins, JTM van der Meer, HI Bax, R Soetekouw, MGJ de Boer, LBS Gelinck, JJ Oosterheert, MA van Agtmael, M Berrevoets, DTP Buis, CH van Werkhoven, MJM Bonten, JE Bosmans, J Branger, S Douiyeb, E Jong, AJJ Lammers, E Sieswerda, JE Stalenhoef, TW Van der Vaart, EA Bij de Vaate, NJ Verkaik, MGA Van Vonderen, PJ De Vries, KCE Sigaloff, E Botman, A Van den Broek, L Buitenhuis, E Buitenwerf, A S Cents, N Engels, J L J Hanssen, A J Meinders, F P N Mollema, L Nagelmaker, M L M van Doorn-Schepens, P Thomopoulos, M Timmer, B van der Wiel

Publikováno v: BMJ Open, Vol 13, Iss 4 (2023)

Introduction A major knowledge gap in the treatment of complicated Staphylococcus aureus bacteraemia (SAB) is the optimal duration of antibiotic therapy. Safe shortening of antibiotic therapy has the potential to reduce adverse drug events, length of

Externí odkaz: https://doaj.org/article/cf2fa20a75a4412a9dbd8b21a6ce2c68

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

National surveillance pilot study unveils a multicenter, clonal outbreak of VIM-2-producing Pseudomonas aeruginosa ST111 in the Netherlands between 2015 and 2017

Autor: I.T.M.A. Overdevest, A. Voss, Marga G van Santen-Verheuvel, M. den Reijer, J. H. Oudbier, M. van der Vusse, S. Dinant, A.G.M. Buiting, A. Stam, B.M.W. Diederen, T. Halaby, P. Schneeberger, B. Zwart, A.E. Muller, Sabine C. de Greeff, M.L. van Ogtrop, E.P.M. van Elzakker, R. Steingrover, A.L.M. Vlek, Heiman F. L. Wertheim, Sandra Witteveen, A. Troelstra, Daan W. Notermans, Jan Kluytmans, D. C. Melles, E. de Jong, E. Heikens, J.W. Dorigo-Zetsma, E.E. Mattsson, Jannette Pirzadian, S. Paltansing, W. Silvis, M. Damen, M. van der Linden, I. J. B. Spijkerman, J. C. Sinnige, T. Schulin, A. Maijer-Reuwer, M. van Rijn, Marjolein C. Persoon, S.P. van Mens, P. de Man, A.J. van Griethuysen, R.W. Bosboom, Erik Bathoorn, J.W. Cohen Stuart, Leo M. Schouls, H.M.E. Frénay, Cornelia C. H. Wielders, K.R.A. van Dijk, D.W. van Dam, Annelot F. Schoffelen, Juliëtte A. Severin, T. A. M. Trienekens, E. I. G. B. de Brauwer, K. Waar, Margreet C. Vos, M.A. Leversteijn-van Hall, A. van Dam, Corné H. W. Klaassen, M. van Trijp, M.J.H.M. Wolfhagen, Marcel G. Mennen, L. Bode, N. Roescher, A. Ott, F.S. Stals

Publikováno v: The Dutch CPE surveillance Study Group 2021, ' National surveillance pilot study unveils a multicenter, clonal outbreak of VIM-2-producing Pseudomonas aeruginosa ST111 in the Netherlands between 2015 and 2017 ', Scientific Reports, vol. 11, no. 1, 21015 . https://doi.org/10.1038/s41598-021-00205-w
Scientific reports, 11(1):21015. Nature Publishing Group
Scientific Reports, 11(1):21015. Nature Publishing Group
Scientific Reports, 11:21015. Nature Publishing Group
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports

Verona Integron-encoded Metallo-beta-lactamase (VIM) is the most frequently-encountered carbapenemase in the healthcare-related pathogen Pseudomonas aeruginosa. In the Netherlands, a low-endemic country for antibiotic-resistant bacteria, no national

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8004dc6859dbb2ff9d0e74a7f854f45d
https://research.vumc.nl/en/publications/7f60079a-a8e9-4123-868e-57719de6a339

Third-generation cephalosporin and carbapenem resistance in Streptococcus mitis/oralis. Results from a nationwide registry in the Netherlands

Autor: J. van Prehn, M.I. van Triest, W. Altorf-van der Kuil, K. van Dijk, J.W.T. Cohen Stuart, A.J.L. Weersink, D. Notermans, M.L. van Ogtrop, M.M. Jager, B.F.M. Werdmuller, B.C. van Hees, P.H.J. van Keulen, J. Alblas, L. Blijboom, S.C. de Greeff, S. Groenendijk, J. van Heereveld, R. Hertroys, J.C. Monen, D.W. Notermans, E.A. Reuland, A.F. Schoffelen, C.C.H. Wielders, S.H.S. Woudt, J.A.J.W. Kluytmans, E.M. Kraan, E.E. Mattsson, F.W. Sebens, E. de Jong, H.M.E. Frénay, B. Maraha, A.J. van Griethuysen, A. Demeulemeester, B.B. Wintermans, M. van Trijp, A. Ott, null E. Bathoorn, M. Lokate, J. Sinnige, E.I.G.B. de Brauwer, F.S. Stals, W. Silvis, L.J. Bakker, J.W. Dorigo-Zetsma, B. Ridwan, K. Waar, A.T. Bernards, S.P. van Mens, N. Roescher, M.H. Nabuurs-Franssen, H. Wertheim, B.M.W. Diederen, L. Bode, M. van Rijn, S. Dinant, O. Pontesilli, P. de Man, M.A. Leversteijn-van Hall, E.P.M. van Elzakker, A.E. Muller, N.H. Renders, D.W. van Dam, A.G.M. Buiting, A.L.M. Vlek, A. Reuland, F.N.J. Frakking, I.T.M.A. Overdevest, R.W. Bosboom, T. Trienekens, G.J.H.M. Ruijs, M.J.H.M. Wolfhagen

Publikováno v: Clinical Microbiology and Infection, 25(4), 518-520. ELSEVIER SCI LTD
Clinical Microbiology and Infection, 25(4), 518-520. Elsevier Ltd.
van Prehn, J, van Triest, M I, Altorf-van der Kuil, W, van Dijk, K, Stuart, J W T C, Weersink, A J L, Notermans, D, van Ogtrop, M L, Jager, M M, Werdmuller, B F M, van Hees, B C, van Keulen, P H J, Alblas, J, Blijboom, L, de Greeff, S C, Groenendijk, S, van Heereveld, J, Hertroys, R, Monen, J C, Notermans, D W, Reuland, E A, Schoffelen, A F, Wielders, C C H, Woudt, S H S, Kluytmans, J A J W, Kraan, E M, Mattsson, E E, Sebens, F W, de Jong, E, Frénay, H M E, Maraha, B, van Griethuysen, A J, Demeulemeester, A, Wintermans, B B, van Trijp, M, Ott, A, e. Bathoorn, Lokate, M, Sinnige, J, de Brauwer, E I G B, Stals, F S, van Dam, D W, Overdevest, I T M A, van Dijk, K, Jager, M M, Reuland, E A, Kluytmans, J A J W, de Jong, E, Wintermans, B B, Overdevest, I T M A, the Dutch National AMR Surveillance Study Group, Trienekens, T, Ruijs, G J H M & Wolfhagen, M J H M 2019, ' Third-generation cephalosporin and carbapenem resistance in Streptococcus mitis/oralis. Results from a nationwide registry in the Netherlands ', Clinical Microbiological and Infection, vol. 25, no. 4, pp. 518-520 . https://doi.org/10.1016/j.cmi.2018.11.021
Clinical Microbiology and Infection, 25(4), 518-520
Clinical Microbiological and Infection, 25(4), 518-520

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a730b3952df0d5d291aad6a7f1c88b7c
https://doi.org/10.1016/j.cmi.2018.11.021

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.